N/A
N=1
Stereotactic Radiation to Decrease Pancreatic Secretions
Pancreatic Fistulae
Bottom Line
View on ClinicalTrials.gov: NCT01656486 ↗Enrolled (actual)
1
Serious AEs
—
Results posted
Apr 2014
Primary outcome: Primary: Decreased Secretions — 1 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Stereotactic Radiation (Radiation)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Wake Forest University Health Sciences
- Primary completion
- Nov 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Decreased Secretions |
1 | — |
Summary
Patients that have undergone pre-operative radiation for pancreatic carcinoma, that upon pathologic examination of the normal portion of the pancreatic gland that was in the radiation field showed acute and chronic changes in the pancreatic cells. The hypothesis for utilizing stereotactic radiation on pancreatic fistulae is that the treatment will decrease pancreatic secretions, thus decreasing autodigestion.
Eligibility Criteria
Inclusion Criteria
- Pancreatic fistula
- Non-surgical candidate
Exclusion Criteria
- Surgical candidate
Data sourced from ClinicalTrials.gov (NCT01656486). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.